Skip to content

The Effects of the Control Strategies of Wearable Lower Limb Rehabilitation Robots

Effects of Control Strategies in Wearable Lower Limb Rehabilitation Robots

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07037849
Enrollment
10
Registered
2025-06-26
Start date
2024-10-23
Completion date
2027-04-22
Last updated
2025-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait Disorders, Gait Training, Stroke

Keywords

Robots, Assistive robots, Trajectory, Torque, Force, Robot kinematics, Knee, Limb, Muscles, Hip

Brief summary

Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers) in a rectangular hospital corridor.

Interventions

DEVICERobot-assisted overground gait training

Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers).

Sponsors

Eighth Affiliated Hospital, Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Stroke patients aged between 18 and 75 years. Patients who are medically stable and able to stand and walk independently for at least 10 meters during rehabilitation. Stroke event occurred at least 3 months ago Patients with impaired lower limb motor function but with some degree of muscle activity in the lower extremities. Patients without severe cognitive impairment and capable of understanding and following the treatment protocol. Patients without severe balance or coordination disorders, able to maintain balance and perform gait training with assistive devices. Patients without lower limb fractures or other serious skeletal issues affecting the lower limbs. Patients without severe cardiovascular or other serious illnesses and able to tolerate the intensity and duration of rehabilitation therapy. Patients willing to participate in the study and able to provide written informed consent.

Exclusion criteria

Severe cognitive impairment that prevents the patient from understanding or complying with the treatment protocol. Severe balance or coordination disorders that prevent the patient from maintaining balance and participating in gait training, even with assistive devices. Other serious motor disorders, such as abnormal muscle tone or ataxia, which may interfere with the effectiveness of rehabilitation therapy. Active cardiovascular disease or other serious systemic illnesses that may affect the patient's safety or treatment outcomes. Lower limb fractures or other serious skeletal issues that may impact the suitability and safety of robot-assisted rehabilitation therapy. Patients currently receiving other rehabilitation or experimental treatments. Patients with skin ulcers, infections, or other severe skin conditions that may interfere with the use and application of robotic devices. Unexplained discomfort or pain symptoms that may limit the patient's ability to participate in rehabilitation therapy. Failure to meet other specific inclusion criteria outlined in the study protocol.

Design outcomes

Primary

MeasureTime frameDescription
Change in 10 Meter Walk Test from baseline gait speedBaseline, immediately after interventionGait speed will be assessed by instructing participants to walk at their maximum safe speed. Each participant will start 1 meter before the designated start line and continue walking until 1 meter past the finish line. The time taken to traverse the measured distance will be recorded using a stopwatch to the nearest one hundredth of a second.

Secondary

MeasureTime frameDescription
Change scores of Lower Extremity Fugl-Meyer Assessment (FMA-LE)Baseline, immediately after interventionThe Lower Extremity Fugl-Meyer Assessment (FMA-LE) is a validated, performance-based scale used to evaluate motor function, reflexes, coordination, and movement synergy of the lower limb in stroke patients. The FMA-LE consists of 17 items, each scored on a 3-point ordinal scale (0 = cannot perform, 1 = performs partially, 2 = performs fully), with a total possible score ranging from 0 to 34. Higher scores indicate better lower limb motor function. Assessments will be performed by trained evaluators according to standardized procedures.

Countries

China

Contacts

Primary ContactShaofeng Zhao
zhaosf1@163.com86 18898773680

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026